A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL

  检 索： 期刊名称 ISSN         高级检索

期刊名称：DARU-JOURNAL OF PHARMACEUTICAL SCIENCES ISSN： 2008-2231 出版频率： Semi-annual 出版社： SPRINGER INT PUBL AG, GEWERBESTRASSE 11, CHAM, SWITZERLAND, CH-6330   出版社网址： http://www.biomedcentral.com/ 期刊网址： http://darujps.biomedcentral.com/ 影响因子： 3.117 主题范畴： PHARMACOLOGY & PHARMACY 变更情况： Newly Added by 2016 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal Aims and scope DARU Journal of Pharmaceutical Sciences is an open access, peer-reviewed journal published on behalf of Tehran University of Medical Sciences. The journal encompasses all fields of the pharmaceutical sciences and presents timely research on all areas of drug conception, design, manufacture, classification and assessment. The term DARU is derived from the Persian name meaning drug or medicine. This journal is a unique platform to improve the knowledge of researchers and scientists by publishing novel articles including basic and clinical investigations from members of the global scientific community in the forms of original articles, systematic or narrative reviews, meta-analyses, letters, and short communications. Open access All articles published by DARU Journal of Pharmaceutical Sciences are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here. As authors of articles published in DARU Journal of Pharmaceutical Sciences you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BioMed Central license agreement. For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed. Article-processing charges DARU Journal of Pharmaceutical Sciences is supported by Tehran University of Medical Sciences. The article-processing charge (APC) that is payable upon editorial acceptance of an article is €850. Note for Iran-based authors For authors based in Iran a discounted APC of €700 and a special mechanism for covering the APC apply. Iran-based authors should enter the code DARU01 during the article submission process. If this code is used, Iran-based authors do not pay an APC to the publisher; instead, TUMS arranges payments with the publisher and will invoice the APC, payable in Iranian Rials, to the authors. If the submitting author's institution is a Member, the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page. Indexing services All articles published in DARU Journal of Pharmaceutical Sciences are included in: Biological Abstracts CABI CAS Embase Global Health MEDLINE PubMed PubMed Central Science Citation Index Expanded Scopus The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink. DARU Journal of Pharmaceutical Sciences has an Impact Factor of 1.654. Peer-review policy Peer review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help Editors determine whether the manuscript should be published in their journal. You can read more about the peer-review process here. DARU Journal of Pharmaceutical Sciences operates a double-blind peer-review system, where the reviewers do not know the names or affiliations of the authors and the reviewer reports provided to the authors are anonymous. The benefit of double-blind peer review is that it allows reviewers to judge the manuscript based on content alone, and they are not unconsciously biased by knowledge of who the authors are. Submitted manuscripts will generally be reviewed by two or more experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. The Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board. Editorial policies All manuscripts submitted to DARU Journal of Pharmaceutical Sciences should adhere to BioMed Central's editorial policies. Citing articles in DARU Journal of Pharmaceutical Sciences Articles in DARU Journal of Pharmaceutical Sciences  should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number. Article citations follow this format: Authors: Title. DARU [year], [volume number]:[article number]. e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. DARU 2009, 1:115. refers to article 115 from Volume 1 of the journal. Appeals and complaints If you wish to appeal a rejection or make a complaint you should, in the first instance, contact the Editor who will provide details of the journal's complaints procedure. For complaints that cannot be resolved with the Editor, the authors should contact the Publisher. Why publish your article in DARU Journal of Pharmaceutical Sciences High visibility DARU Journal of Pharmaceutical Sciences's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience.  Speed of publication DARU Journal of Pharmaceutical Sciences offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF. Flexibility Online publication in DARU Journal of Pharmaceutical Sciences gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles). Promotion and press coverage Articles published in DARU Journal of Pharmaceutical Sciences are included in article alerts and regular email updates. Some may be highlighted on DARU Journal of Pharmaceutical Sciences’s pages and on the BioMed Central homepage. In addition, articles published in DARU Journal of Pharmaceutical Sciences may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in DARU Journal of Pharmaceutical Sciences. A list of articles recently press-released by journals published by BioMed Central is available here. Copyright As an author of an article published in DARU Journal of Pharmaceutical Sciences you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BioMed Central license agreement). For further information about the advantages of publishing in a journal from BioMed Central, please click here. Instructions to Authors Submission guidelines Our 3-step submission process Before you submit Now you’ve identified a journal to submit to, there are a few things you should be familiar with before you submit. Make sure you are submitting to the most suitable journal - Aims and scope Understand the costs and funding options - Fees and funding Make sure your manuscript is accurate and readable - Language editing services Understand the copyright agreement - Copyright Ready to submit To give your manuscript the best chance of publication, follow these policies and formatting guidelines. DARU Journal of Pharmaceutical Sciences publishes the following article types: Research article Case report Commentary Letter to the Editor Review Short communication Click the relevant link to find style and formatting information for the article you are going to submit. General formatting rules for all article types - Preparing your manuscript Make sure your submission is complete - Prepare supporting information Copyright and license agreement - Conditions of publication Read and agree to our Editorial Policies - Editorial policies Submit and promote After acceptance, we provide support so your article gains maximum impact in the scientific community and beyond. Who decides whether my work will be accepted? - Peer-review policy Want to submit to a different journal? - Manuscript transfers Spreading the word - Promoting your publication Submit your manuscript in Editorial Manager Editorial Board Editor-in-Chief Mohammad Abdollahi, Tehran University of Medical Sciences, Iran Section Editors Mohammad Ali Faramarzi, Tehran University of Medical Sciences, Iran Alireza Foroumadi, Tehran University of Medical Sciences, Iran Kambiz Gilani, Tehran University of Medical Sciences, Iran Amir Reza Jalilian, International Atomic Energy Agency (IAEA), Austria Hossein Khalili, Tehran University of Medical Sciences, Iran Mahnaz Khanavi, Tehran University of Medical Sciences, Iran Ali Akbar Moghadamnia, Babol University of Medical Sciences, Iran Morteza Mahmoudi, Tehran University of Medical Sciences, Iran  Shekoufeh Nikfar, Tehran University of Medical Sciences, Iran Ali Nokhodchi, University of Sussex, UK Roja Rahimi, Tehran University of Medical Sciences, Iran Mohammad Reza Rouini, Tehran University of Medical Sciences, Iran Alireza Vatanara, Tehran University of Medical Sciences, Iran Editorial Board Bazigha Abdul-Rasool, Dubai Pharmacy College, Dubai, U.A.E Khosrow Adeli, The Hospital for Sick Children, Canada Shahin Akhondzadeh, Tehran University of Medical Sciences, Iran Massoud Amanlou, Tehran University of Medical Sciences, Iran Gholameza Amin, Tehran University of Medical Sciences, Iran Fatemeh Atyabi, Tehran University of Medical Sciences, Iran Mahdi Balali-Mood, Mashhad University of Medical Sciences, Iran Maciej Banach, Polish Lipid Association (PoLA), Poland Davood Beiki, Tehran University of Medical Sciences, Iran Abdolmajid Cheraghali, University of Baqiyatallah Medical Sciences, Iran Rassoul Dinarvand, Tehran University of Medical Sciences, Iran Hassan Ebrahimzadeh, University of Tehran, Iran Padideh Ghaeli, Tehran University of Medical Sciences, Iran Taravat Ghafourian, University of Kent, UK Mehrdad Hamidi, Zanjan University of Medical Sciences, Iran A. Wallace Hayes, Harvard School of Public Health, USA David Henry, Institute for Clinical Evaluative Sciences, Canada Hossein Hosseinzadeh, Mashad University Medical School, Iran Mohammad Shamim Jairajpuri, Aligarh Muslim University, India Fakhroldin Jamali, University of Alberta, Canada Mahmoud Kajbaf, Neurosciences Centre of Excellence for Drug Discovery, Italy Abbas Kebriaeezadeh, Tehran University of Medical Sciences, Iran Shahram Khademi, University of Iowa, USA Ali Khalaj, Tehran University of Medical Sciences, Iran Xiangrui Liu, Zhejiang University, China Soraya Madani, Novartis, UK Firouz Matloubi-Moghaddam, Sharif University of Technology, Iran Reza Mehvar, Texas Tech University Health Sciences Center, USA Mehran Moghadam, Celgene, USA Mojtaba Mojtahedzadeh, Tehran University of Medical Sciences, Iran Grainne Moloney, UNICEF, Kenya Peter J. O'Brien, University of Toronto, Canada Yadollah Omidi, Tabriz University of Medical Sciences, Iran Keykavous Parang, Chapman University, USA Ali Pourmand, George Washington University, USA Morteza Rafiee-Tehrani, Tehran University of Medical Sciences, Iran Amin Rostami-Hodjegan, University of Manchester, UK Satyajit D. Sarker, Liverpool John Moores University, UK Ahmadreza Shahverdi, Tehran University of Medical Sciences, Iran Mohammad Sharifzadeh, Tehran University of Medical Sciences, Iran Hosnieh Tajerzadeh, Tehran University of Medicial Sciences, Iran Emad Tajkhorshid, University of Illinois, USA Leila Vali, Kuwait University, Kuwait Khushwant S. Yadav, Rajeev Gandhi College of Pharmacy, Bhopal, India